Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02561455
Title Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications

Advanced Solid Tumor

acute myeloid leukemia

Therapies

Gilteritinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Site US10005 Phoenix Arizona 85084 United States Details
Site US10003 Baltimore Maryland 21201 United States Details
Site US10006 New York New York 10032 United States Details
Site US10007 New York New York 10065 United States Details
Site US10001 Cleveland Ohio 44195 United States Details
Site US10004 Hershey Pennsylvania 17033 United States Details
Site US10008 Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field